Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-28

FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's original application for raloxifene hydrochloride as a generic medication for postmenopausal osteoporosis and to red…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

ORIG AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)